We recently updated our Privacy Notice and Terms of Use.
Med-IQ
Recognizing the Risk and Providing Optimal Care to Veterans With Heart Failure
PDF Publication PDF Publication

Recognizing the Risk and Providing Optimal Care to Veterans With Heart Failure


Released:
12/22/17
Expires:
12/21/18

Maximum Credits:

1.0
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

PDF Publication PDF Publication
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.
Released:
12/22/17

Expires:
12/21/18

Maximum Credits:
1.0
PDF Publication PDF Publication
By clicking "Continue," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Notice and Terms of Use.

Released:
12/22/17
Expires:
12/21/18


Maximum Credits:
1.0


Overview: This publication explores risk factors for heart failure that are unique to veterans and reviews treatment strategies based on the updated heart failure guidelines. The clinical trials that led to these updated guidelines are also discussed.

CME Information:

Faculty
John R. Teerlink, MD, FACC, FAHA, FESC, FHFA, FHFSA, FRCP (UK)
Professor of Medicine
University of California, San Francisco
Director, Heart Failure Program
Director, Clinical Echocardiography
San Francisco VA Medical Center
San Francisco, CA

Peter P. Toth, MD, PhD, FASPC, FAAFP, FCCP, FAHA, FESC, FACC
Professor of Clinical Family and Community Medicine
University of Illinois College of Medicine
Peoria, IL
Professor of Clinical Medicine
Michigan State University College of Osteopathic Medicine
East Lansing, MI
Adjunct Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD
Director of Preventive Cardiology
CGH Medical Center
Sterling, IL

Activity Planners
Christie Avraamides, PhD
Clinical Content Manager
Med-IQ
Baltimore, MD

Rebecca L. Julian, MS, ELS
Senior Manager, Editorial
Med-IQ
Baltimore, MD

Samantha Gordon
CME Specialist
Med-IQ
Baltimore, MD

Kathryn Schaefer, MSN, RN
Manager
Lead Nurse Planner
Med-IQ
East Lansing, MI
 
Writer
Christine Welniak
Playa del Rey, CA
 
Learning Objectives
Upon completion, participants should be able to:

  • Identify risk factors for HF including those unique to veterans
  • Describe strategies to manage comorbid conditions or risk factors among veterans with or at risk of HF
  • Incorporate recent clinical evidence and guideline recommendations to provide personalized care for veterans with chronic HF

Target Audience
This activity is intended for primary care physicians, cardiologists, nurses, and pharmacists who manage the health of about 18 million beneficiaries in the federal healthcare system, including the VA and the military through all branches of service in the DoD.
 
Series Overview/Statement of Need
The Department of Veterans Affairs (VA) Veterans Health Administration provides healthcare services to approximately 9 million veterans. Heart failure (HF) is the primary reason for admission at VA Medical Centers, and its prevalence is expected to increase in the coming years. Indeed, the rise in obesity and diabetes, which are associated with an increased risk of HF, will likely contribute to this increased prevalence. In addition, veterans have unique risk factors for HF that clinicians need to be able to recognize to appropriately manage these patients. Furthermore, in 2017, the American College of Cardiology, American Heart Association, and Heart Failure Society of America jointly published a focused update on the pharmacologic management of HF to provide guidance regarding the use of two new medical therapies approved for the treatment of HF. Thus, clinicians need to be aware of the updated guidelines to provide optimal care to their patients.
 
Providership Statement
Provided by Med-IQ.

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Med-IQ is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This nursing activity has been approved for up to 1.0 contact hour.

acpe logoMed-IQ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hour (0.1 CEU) of credit for pharmacists. ACPE #0476-0000-17-003-H01-P. This knowledge-based activity is designed for all pharmacists.
 
Physician assistants and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.

Medium/Method of Participation
This CME/CE/CPE activity consists of a 1.0-credit publication. To receive credit, complete the pre-survey, read the introductory CME/CE/CPE material, read the publication, and complete the post-survey, evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.

Initial Release Date: December 22, 2017
Expiration Date: December 21, 2018
Estimated Time to Complete This Activity: 1 hour

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
 
Disclosure Statement
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
 
John R. Teerlink, MD, FACC, FAHA, FESC, FHFA, FHFSA, FRCP (UK)
Consulting fees/advisory boards: Abbott Laboratories, Amgen, Bristol-Myers Squibb, Cytokinetics, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Stealth BioTherapeutics
Contracted research: Abbott Laboratories, Amgen, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb, Celyad, Medtronic, Inc., Novartis Pharmaceuticals Corporation, Stealth BioTherapeutics

Peter P. Toth, MD, PhD, FASPC, FAAFP, FCCP, FAHA, FESC, FACC
Fees received for promotional/non-CME activities: Novartis Pharmaceuticals Corporation

Christine Welniak
Other (medical writer): Corindus, Inc.

The peer reviewers and other activity planners have no financial relationships to disclose.

Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
 
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Contact Information       
For CME-related questions or comments about this activity, please contact Med-IQ.
Call (toll-free) 866 858 7434 or email info@med-iq.com.
                      
Hardware/Software Requirements
Operating System
Microsoft Windows® 8, Windows 7
Mac OS 10.7 (Lion) or newer

Browser
Microsoft Internet Explorer 8.0 or later
Mozilla Firefox - latest version
Download: http://www.mozilla.org/en-US/firefox/new/
 
Google Chrome - latest version
Download: http://www.google.com/chrome
 
Apple Safari - latest version
Download: http://www.apple.com/safari/download/

PDF Viewer
Adobe Acrobat Reader® or Adobe Reader
Download: http://get.adobe.com/reader/

Adobe Flash Player
Adobe Flash Player 9 or later
Download: http://get.adobe.com/flashplayer/ 
 
For technical support, go to http://www.med-iq.com/index.cfm?fuseaction=content.support.

ADA Statement
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
 
Disclaimer
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: http://www.med-iq.com/privacy-statement/.

Acknowledgment of Commercial Support
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Copyright
© 2017 Med-IQ, LLC

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or email info@med-iq.com. For technical assistance, please refer to our support manual.